DAVID BENTON: Open Payments
NPI 1952319865 · GILBERT, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,101 in 106 payments from 24 companies in 2025. Trend: 2023 $2,442 · 2024 $2,056 · 2025 $2,101
Food & beverage: $2,101
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 12 | $504 |
| Novo Nordisk Inc | 11 | $276 |
| ABBVIE INC. | 23 | $261 |
| PFIZER INC. | 12 | $199 |
| Amgen Inc. | 12 | $140 |
| Lilly USA, LLC | 5 | $103 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $94 |
| GlaxoSmithKline, LLC. | 4 | $79 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $67 |
| Abbott Laboratories | 2 | $47 |
Products named: BREZTRI, AIRSUPRA, Ozempic, NURTEC ODT, UBRELVY, OTEZLA, QULIPTA, MOUNJARO.
Industry payments across AZ — which companies pay providers there.
